We gladly answer your questions concerning the contribution of admedicum® at the below mentioned events. Registration shall be submitted via the concerned organizers exclusively.

 Enter event

MedTech Summit and MedtecLIVE 2019

Scientific and market-specific presentations will deliver insights into cross-technology approaches, industry trends and processes. The agenda will feature interactive and interdisciplinary items to help you generate new solutions. For more information please klick here.

 Enter event

BMC e.V. Discussion Round: AMNOG 2.0

admedicum takes part in the background discussions of the BMC e.V. on the developments in the course of the AMNOG. Experts will speak and discuss opportunities and challenges - including Prof. Dr. James Robinson (UC Berkeley, California), who as an expert on the American health and pharmaceutical market will talk about his impressions of the AMNOG. Learn more

 Enter event

German ePharma Day

The German e-Pharma day will examine the consequences of the new regulations from different viewpoints: from patient rights to data protection in clinical research with a special focus on the national adaptations. For more information please klick here.

 Enter event

Register here!


The Fraunhofer Institute for Manufacturing Engineering and Automation IPA and admedicum® Business for Patients therefore invite patient organizations, medical technology companies, physicians and other health experts, rehabilitation and research institutions and associations to a conference in Stuttgart in order to get in touch with each other.

 Enter event

HTAi 2019 Annual Meeting

HTAi Annual Meeting provides an ideal presentation and discussion platform for opportunities, emerging challenges and possible threats. Trends for harmonization and standardization are confronted by progressive digitalization, disruptive innovations, and the questioning of established evidence requirements. For more information please klick here.

 Enter event

Forum Seminar in Berlin: Update GSAV - Financing of innovative therapies

Learn from the experience and exchange with our experts about CAR-T and other treatment breakthroughs in statutory health insurance and their reimbursement. Further information can be found here.